EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen

Seyed Mohammad Valizadeh Toosi iD, Sahar Feyzi, Arash Kazemi

The Korean Journal of Gastroenterology · 2024

DOI: 10.4166/kjg.2024.012 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Korean Journal of Gastroenterology, 2024. Verfasst von Seyed Mohammad Valizadeh Toosi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Amoxicillin, Anti-Bacterial Agents, Clarithromycin, Drug Therapy, Combination. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mazandaran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmoxicillinAnti-Bacterial AgentsClarithromycinDrug Therapy, CombinationEsomeprazoleHelicobacter InfectionsHelicobacter pyloriMetronidazoleAdultAgedFemaleHumansMaleMiddle AgedDrug Administration SchedulePantoprazoleProton Pump InhibitorsTreatment Outcome

Stichwörter der Autor:innen

Concomitant quadruple therapyEradicationH. pyloriHigh dose dual therapy

Substanzen

AmoxicillinAnti-Bacterial AgentsClarithromycinEsomeprazoleMetronidazolePantoprazoleProton Pump Inhibitors

Autor:innen und Institutionen

  • Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Medicine faculty, Mazandaran University of Medical Sciences, Sari, Iran.

ORCID-Profile: Seyed Mohammad Valizadeh Toosi

Förderung

  • Mazandaran University of Medical Sciences

Zitieren

APA

Valizadeh Toosi, S. M., Feyzi, S., & Kazemi, A. (2024). Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen. The Korean Journal of Gastroenterology. https://doi.org/10.4166/kjg.2024.012

Vancouver

Valizadeh Toosi SM, Feyzi S, Kazemi A. Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen. The Korean Journal of Gastroenterology. 2024. doi:10.4166/kjg.2024.012

BibTeX
@article{ValizadehToosi2024,
  author = {Valizadeh Toosi, Seyed Mohammad and Feyzi, Sahar and Kazemi, Arash},
  title = {Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen},
  journal = {The Korean Journal of Gastroenterology},
  year = {2024},
  doi = {10.4166/kjg.2024.012}
}
Kostenlos starten →